市場調査レポート
商品コード
1347169

目薬市場の2030年までの予測-タイプ、用途、購入形態、地域による世界分析

Eye Drops Market Forecast to 2030 - Global Analysis by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, Purchase Mode (OTC and Prescription), and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 188 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
目薬市場の2030年までの予測-タイプ、用途、購入形態、地域による世界分析
出版日: 2023年08月09日
発行: The Insight Partners
ページ情報: 英文 188 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

目薬市場は、2022年に157億9,327万米ドルと評価され、2030年には237億8,845万米ドルに達すると予測され、2022年から2030年までのCAGRは5.3%と推定されます。

眼科疾患の主な発展と加齢に伴う眼疾患の高い発生率が市場開拓の主な原動力となっています。また、ライフスタイルの変化や眼科医療への取り組みの高まりも、今後数年間の目薬市場の活性化につながると予想されます。

ライフスタイルの変化が目薬市場の成長要因目薬市場の今後の成長要因

眼疾患は、スマートフォン、ノートパソコン、コンピュータの使用の増加により、生活習慣病の中でかなりのシェアを占めています。スクリーン使用時間の増加を伴う現代のライフスタイルは、目に関連する問題を引き起こす原因となっています。このテクノロジーの時代には、目の健康が著しく損なわれています。長時間のパソコン作業は、やがて目の健康に影響を及ぼします。慢性的な目の病気や屈折異常のある人は、デジタル眼精疲労(DES)を発症するリスクが高いです。

スマートフォン、タブレット、iPad、ノートパソコンから発せられる青色光線に過度にさらされることも、深刻な眼障害を引き起こします。COVID-19の発生により、すべての企業がCOVID-19の蔓延を防ぐために在宅勤務(WFH)を選択しました。WFHの動向の高まりは、社会人のスクリーン使用時間を増加させ、目に関連する問題をさらに加速させています。Springer誌が発表した研究によると、COVID-19の封鎖期間中、デジタル機器の長時間使用が増加し、サウジアラビアの人々は眼精疲労の増加を訴えました。Frontiers誌が発表した研究によると、デジタル機器を連続2時間以上繰り返し使用することで、過剰な収容力が要求され、DESを発症する危険性が高いといわれています。COVID-19の蔓延はかなり抑制されているが、多くの企業は全体の支出を減らすために従業員にWFHの継続を認めています。勤務場所に関するこのような柔軟性が、スクリーン使用時間の増加につながっています。このようなライフスタイルの変化は、やがて目の健康を損ない、目薬の需要を増大させる。

製品回収が目薬市場の成長を妨げる

医療機関はここ数年、輸液ポンプの有害事象について多くの報告を受けています。目薬製品回収の主な理由は、包装不良、細菌感染、充血、痛みなどです。目薬に関連する最近の製品リコールを以下にいくつか挙げます。

2023年2月、FDAはEzriCare, LLCおよびDEL南米 Pharmaが販売するEzriCare人工涙液の細菌汚染の可能性があるとして、使用を避けるよう警告を発しました。この市販製品は55人の患者に重篤な眼感染症を引き起こし、うち1人が死亡しました。感染症の原因は薬剤耐性菌である緑膿菌でした。

2023年3月、アポテックス社はブリモニジン酒石酸塩点眼液のキャップに亀裂があったため、6ロットの自主回収を開始しました。同処方薬は開放隅角緑内障や高眼圧症の患者に使用されます。

2023年3月、FDAはPharmedica USA社がPurely Soothing Dropsの2ロットを自主回収したと発表しました。この市販製品は非ステロイド性の可能性があるため回収されました。.

2022年1月、Teva Pharmaceuticals社は「不純物検査不合格」のため、人気のある目薬製品の一部ロットをリコールしました。このリコールには、使用期限が2023年後半から2024年前半に達する70万本以上のボトルが含まれていました。

このように、目薬に関連する安全性への懸念や目薬のリコールは、目薬市場の成長を妨げています。

目薬市場、タイプ別インサイト

目薬市場はタイプ別に、抗生物質、ホルモン剤、人工涙液、その他に区分されます。2022年の市場シェアは抗生物質分野が大きいです。しかし、ホルモンセグメントは予測期間中により高いCAGRを記録すると予測されています。女性の視力は、ホルモンレベルの変化によって大きく影響を受ける。エストロゲンとプロゲステロンのレベルの変化は、目の油腺に影響を与え、乾燥につながります。エストロゲンの変動は主に目の乾燥を引き起こす原因です。更年期の女性はドライアイのリスクが高いです。この症状は、処方された目薬を使って治療することができます。ホルモンの変化によって引き起こされる眼病を治療する目薬を開発するために、いくつかの研究活動が行われています。甲状腺関連の自己免疫疾患は甲状腺レベルの変化を引き起こす可能性があり、その結果ドライアイを引き起こす可能性があります。したがって、前述の要因は、ホルモン目薬セグメントの目薬市場を押し上げると予想されます。

目薬市場、用途別インサイト

用途別では、目薬市場は眼疾患、アイケア、その他に区分されます。眼疾患セグメントはさらにドライアイ、緑内障、白内障、その他に細分化されます。2022年の市場シェアは、眼疾患分野が大きいです。しかし、アイケア分野は予測期間中に最も高いCAGRを記録すると予測されています。目を保護することで、失明や視力低下、白内障や緑内障などの眼病の確率を減らすことができます。アイケア用の目薬は、目の視力を保護するのに役立ちます。眼科手術の後、患者は治癒を促進するための様々な指示を期待することができます。目薬は術後のケアにも欠かせないです。眼は合併症の影響を受けやすいため、一般的に眼科医は感染を防ぐために抗生物質の目薬を処方し、炎症を抑えるために抗炎症剤の目薬を処方します。

目薬市場:購入形態別インサイト

購入形態に基づき、目薬市場は処方薬とOTCに二分されます。処方箋セグメントが2022年の市場シェアで最大を占め、予測期間中に市場でより高いCAGRを記録すると予測されています。患者が眼科医を訪れるのは、市販薬(OTC)を長期間使用しても効果が得られない場合です。処方される目薬は、ドライアイや緑内障患者の眼圧下降などの疾患を治療します。医師から処方される抗生物質の目薬は、細菌性眼感染症を治療します。レスタシス(シクロスポリン点眼液)は、ドライアイ(瘢痕性角結膜炎)の治療薬として承認されています。さらに、緑内障患者の眼圧下降のために多くの薬が利用可能です。これらの目的でよく使用される目薬は、ラタノプロスト、トラボプロスト、ビマトプロスト、タフルプロストなどのプロスタグランジンアナログ、チモロール、ベタキソロールなどのβ遮断薬、ブリモニジンなどのα2アドレナリン作動薬です。

目薬市場に関するレポート作成時に参照した主な一次情報および二次情報には、世界保健機関(WHO)、疾病対策予防センター(CDC)、欧州医療機関(EMA)、汎米保健機関(PAHO)などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要インサイト
  • 目薬市場、地域別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 目薬市場情勢

  • 概要
  • PEST分析
    • 北米PEST分析
    • 欧州PEST分析
    • アジア太平洋PEST分析
    • 中南米PEST分析
    • 中東・アフリカPEST分析
  • エコシステム分析
    • バリューチェーンのベンダー一覧
  • パイプライン分析
  • 購入モード

第5章 目薬市場:主要産業力学

  • 市場促進要因
    • 眼科疾患の有病率の上昇
    • 加齢に伴う眼疾患の高い有病率
  • 主な市場抑制要因
    • 製品回収
  • 主な市場機会
    • 眼科医療への取り組みの高まり
  • 今後の動向
    • ライフスタイルの変化
  • 影響分析

第6章 目薬市場:世界市場分析

  • 目薬市場の売上高、2022年~2030年
  • 概要
  • 目薬市場、2022年・2030年、タイプ別売上高シェア(%)
  • 抗生物質
  • 人工涙液
  • ホルモン剤
  • その他

第7章 目薬の世界市場:2030年までの収益と予測:用途別

  • 概要
  • 目薬市場、2022年・2030年、用途別売上高シェア(%)
  • 眼疾患
  • アイケア
  • その他

第8章 目薬の世界市場:2030年までの収益と予測:購入形態別

  • 概要
  • 目薬市場2022年・2030年タイプ別売上高シェア(%)
  • 処方薬
  • 一般用医薬品

第9章 目薬の世界市場:2030年までの収益と予測:地域別分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第10章 COVID-19前後の目薬市場への影響

  • COVID-19前後の影響

第11章 目薬市場-業界情勢

  • 概要
  • 目薬市場における成長戦略(%)
  • オーガニック
  • 無機

第12章 企業プロファイル

  • Akorn Operating Company LLC
  • Alcon AG
  • Pfizer Inc
  • Prestige Consumer Healthcare Inc.
  • Rohto Pharmaceutical Co Ltd
  • Sager Pharma Kft
  • Similasan Corp
  • AbbVie Inc
  • Bausch & Lomb Inc
  • Biomedica Pvt Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Eye Drops Market Segmentation
  • Table 2. List of Vendors
  • Table 3. North America Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Germany Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. France Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Italy Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Italy Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Italy Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Spain Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Spain Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Spain Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Rest of Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Rest of Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Rest of Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Asia Pacific Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. China Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China Eye Drops Market, by Eye Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. China Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Japan Eye Drops Market, by Purchase Mode- Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. India Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Australia Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. South Korea Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Rest of Asia Pacific Eye Drops Market, by Purchase Mode- Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East & Africa Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East & Africa Eye Drops Market, by Eye Disease by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Middle East & Africa Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa Eye Drops Market, by Eye Disease by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South Africa Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia Eye Drops Market, by Eye Disease by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Saudi Arabia Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. UAE Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. UAE Eye Drops Market, by Eye Disease by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. UAE Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East & Africa Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East & Africa Eye Drops Market, by Eye Disease by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Rest of Middle East & Africa Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South & Central America: Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America: Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South & Central America: Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South & Central America: Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Brazil: Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil: Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Brazil: Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Brazil: Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Argentina: Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina: Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Argentina: Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Argentina: Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of South & Central America: Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America: Eye Drops Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of South & Central America: Eye Drops Market, for Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of South & Central America: Eye Drops Market, By Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Organic Developments in the Eye Drop Market
  • Table 112. Inorganic Developments in the Eye drop Market
  • Table 113. Glossary of Terms, Eye Drops Market

List Of Figures

  • Figure 1. Eye Drops Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Pipeline Analysis
  • Figure 8. Eye Drops Market: Key Industry Dynamics
  • Figure 9. Eye Drops Market: Impact Analysis of Drivers and Restraints
  • Figure 10. Eye Drops Market Revenue (US$ Mn), 2020 - 2030
  • Figure 11. Global Eye Drops Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 12. Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 13. Antibiotics: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Artificial Tears: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Hormones: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 18. Eye Diseases: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Dry Eye: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Glaucoma: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cataract: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Eye Cares: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Prescription: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. OTC: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. North America: Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 31. US: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Canada: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Mexico: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Europe: Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 35. Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Europe: Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 37. Germany: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. France: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. UK: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Italy: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. Spain: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. Rest of Europe: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Asia Pacific: Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 44. Asia Pacific Eye Drops Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Asia Pacific: Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 46. China: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Japan: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. India: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Australia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. South Korea: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Rest of Asia Pacific: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Middle East & Africa: Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 53. Middle East & Africa Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Middle East & Africa: Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 55. South Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. Saudi Arabia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. UAE: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 58. Rest of Middle East & Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. South & Central America: Eye Drops Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 60. South & Central America: Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 61. South & Central America: Eye Drops Market Share by Country - 2022 & 2030, (%)
  • Figure 62. Brazil: Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 63. Argentina: Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 64. Rest of South & Central America: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 65. Pre and Post COVID-19 Impact
  • Figure 66. Growth Strategies in the Eye Drop Market (%)
目次
Product Code: TIPRE00011308

The eye drops market was valued at US$ 15,793.27 million in 2022 and is expected to reach US$ 23,788.45 million by 2030; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the key driving factors behind the market development. Also, changing lifestyle and rising initiatives for eye care is expected to fuel the eye drops market in the upcoming years.

Changing Lifestyle is Responsible for Eye Drops Market Eye Drops Market Growth in the Upcoming Years

Eye diseases hold a substantial share in lifestyle diseases due to the increased use of smartphones, laptops, and computers. The modern lifestyle, which involves increased screen time, is responsible for triggering eye-related problems. Eye health is significantly compromised in this technological era. Working on computers for a long time eventually affects the health of the eyes. Individuals with chronic eye problems and refractive errors are at higher risk of developing digital eye strain (DES).

Extreme exposure to blue rays emitting from smartphones, tablets, iPads, and laptops also causes serious eye damage. Due to the COVID-19 outbreak, all companies opted for work-from-home (WFH) to prevent the spread of COVID-19. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by the Springer, during the COVID-19 lockdown, increase in longer time usage of digital devices, population in Saudi Arabia complained about increase eye strain. According to a study published by Frontiers, the repeated use of digital devices for more than two continuous hours is putting the user at a great risk of developing DES due to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. This flexibility with regard to work location has led to an increase in screen time. Such lifestyle changes will eventually damage eye health, generating a greater demand for eye drops.

Product Recalls Hamper Eye Drops Market Growth

Medical agencies have received many reports of adverse events involving infusion pumps in the last few years. The main reasons for recalling eye drop products are defective packaging, bacterial infection, redness, and pain. A few recent product recalls related to eye drops are mentioned below.

In February 2023, the FDA issued a warning note to avoid the use of EzriCare Artificial Tears, distributed by EzriCare, LLC and DELSAM Pharma, because of potential bacterial contamination. The over-the-counter product caused severe eye infections in 55 patients, including one death. The infections were caused by a drug-resistant bacteria, Pseudomonas aeruginosa.

In March 2023, Apotex Corp. initiated a voluntary recall for six lots of Brimonidine Tartrate Ophthalmic Solution due to cracks in the caps. The prescription drops are used for patients with open-angle glaucoma or ocular hypertension.

In March 2023, the FDA announced that Pharmedica USA voluntarily recalled two lots of Purely Soothing Drops. This over-the-counter product was recalled due to the possibility of non-sterility. .

In January 2022, Teva Pharmaceuticals recalled certain batches of their popular eye drop products due to a "failed impurities" test. This recall included over 700,000 bottles with expiration dates reaching late 2023 and early 2024.

Thus, the safety concerns associated with eye drops and recalls of eye drops hinder the eye drops market growth.

Eye Drops Market, By Type-Based Insights

Based on type, the eye drops market is segmented into antibiotics, hormones, artificial tears, and others. The antibiotics segment held a larger market share in 2022. However, the hormones segment is anticipated to register a higher CAGR during the forecast period. Eye vision in females is largely affected by changing hormone levels. Changing levels of estrogen and progesterone impact oil glands in the eye, leading to dryness. Estrogen fluctuations are primarily responsible for causing dryness in the eyes. Women who are at the stage of menopause are at high risk of suffering from dry eye conditions. The condition can be treated using prescribed eye drops. Several research activities are being conducted to develop eye drops that treat eye diseases caused due to hormonal changes. Thyroid-related autoimmune diseases may lead to thyroid level changes, which can consequently cause dry eye. Thus, the aforementioned factors are anticipated to boost the eye drops market for the hormone drops segment.

Eye Drops Market, By Application-Based Insights

Based on application, the eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment is further sub-segmented into dry eye, glaucoma, cataract, and others. The eye diseases segment held a larger market share in 2022. However, the eye care segment is anticipated to register a highest CAGR during the forecast period. By protecting the eyes, one can reduce the odds of blindness and vision loss, and eye diseases such as cataracts and glaucoma. The eye drops for eye care helps to protect the sight of eyes. After any eye surgery, patients can expect various instructions to help promote healing. eye drops are also essential in post-operative care. As your eyes are more vulnerable to complications, eye doctor generally prescribe antibiotic eye drops to prevent infection and anti-inflammatory eye drops to control inflammation.

Eye Drops Market, By Purchase Mode-Based Insights

Based on purchase mode, the eye drops market is bifurcated into prescription and OTC. The prescription segment held the largest share of the market in 2022 and is anticipated to register the higher CAGR in the market during the forecast period. Patients visit an ophthalmologist when they do not get results with prolonged use of available over-the-counter (OTC) drugs. Prescribed eye drops treat disorders such as dry eye disease and lowering intraocular pressure in glaucoma patients. Antibiotic eye drops prescribed by a doctor treat bacterial eye infections. Restasis (cyclosporine ophthalmic) eye drops are approved to treat dry eye disease (called keratoconjunctivitis sicca). Further, many medicines are available for lowering the IOP in glaucoma patients. Frequently used eye drops available for these purposes are prostaglandin analogs such as Latanoprost, Travoprost, Bimatoprost, and Tafluprost; beta-blockers such as Timolol and Betaxolol; and alpha-2 adrenergic agonists such as Brimonidine.

A few of the major primary and secondary sources referred to while preparing the report on the eye drops market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Medical Agency (EMA), and Pan American Health Organization (PAHO).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the eye drops market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the eye drops market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the eye drops market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Eye Drops Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Eye Drops Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain
  • 4.4 Pipeline Analysis
  • 4.5 Purchase Mode

5. Eye Drops Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Ophthalmic Diseases
    • 5.1.2 High Prevalence of Age-Related Eye Diseases
  • 5.2 Key Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Initiatives for Eye Care
  • 5.4 Future Trends
    • 5.4.1 Changes in Lifestyle
  • 5.5 Impact Analysis

6. Eye Drops Market - Global Market Analysis

  • 6.1 Eye Drops Market Revenue (US$ Mn), 2022 - 2030
  • 6.2 Overview
  • 6.3 Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.4 Antibiotics
    • 6.4.1 Overview
    • 6.4.2 Antibiotics: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Artificial Tears
    • 6.5.1 Overview
    • 6.5.2 Artificial Tears: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Hormones
    • 6.6.1 Overview
    • 6.6.2 Hormones: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

7. Global Eye Drops Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Eye Diseases
    • 7.3.1 Overview
    • 7.3.2 Eye Diseases: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Dry Eye
        • 7.3.2.1.1 Overview
      • 7.3.2.2 Dry Eye: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.3 Glaucoma
        • 7.3.2.3.1 Overview
        • 7.3.2.3.2 Glaucoma: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.4 Cataract
        • 7.3.2.4.1 Overview
        • 7.3.2.4.2 Cataract: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.5 Others
        • 7.3.2.5.1 Overview
        • 7.3.2.5.2 Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Eye Cares
    • 7.4.1 Overview
    • 7.4.2 Eye Cares: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

  • 8.1 Overview
  • 8.2 Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • 8.3 Prescription
    • 8.3.1 Overview
    • 8.3.2 Prescription: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 OTC
    • 8.4.1 Overview
    • 8.4.2 OTC: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. Eye Drops Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 9.1 North America: Eye Drops Market
    • 9.1.1 Overview
    • 9.1.2 North America: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.1.3 North America: Eye Drops Market, by Type, 2020-2030 (US$ Million)
    • 9.1.4 North America: Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 9.1.4.1 North America: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    • 9.1.5 North America: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.1.5.1 US: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.1.1 Overview
        • 9.1.5.1.2 US: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.1.3 US: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.1.5.1.4 US: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.1.5.1.4.1 US: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.1.5.1.5 US: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.1.5.2 Canada: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.2.1 Overview
        • 9.1.5.2.2 Canada: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.2.3 Canada: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.1.5.2.4 Canada: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.1.5.2.4.1 Canada: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.1.5.2.5 Canada: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.1.5.3 Mexico: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.3.1 Overview
        • 9.1.5.3.2 Mexico: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.5.3.3 Mexico: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.1.5.3.4 Mexico: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.1.5.3.4.1 Mexico: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.1.5.3.5 Mexico: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  • 9.2 Europe: Eye Drops Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.2.3 Europe: Eye Drops Market, by Type, 2020-2030 (US$ Million)
    • 9.2.4 Europe: Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 9.2.4.1 Europe: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
    • 9.2.5 Europe: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
    • 9.2.6 Europe: Eye Drops Market, by Country, 2022 & 2030 (%)
      • 9.2.6.1 Germany: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.1.1 Overview
        • 9.2.6.1.2 Germany: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.1.3 Germany: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.1.4 Germany: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.1.4.1 Germany: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.2.6.1.5 Germany: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.2.6.2 France: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.2.1 Overview
        • 9.2.6.2.2 France: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.2.3 France: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.2.4 France: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.2.4.1 France: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.2.6.2.5 France: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.2.6.3 UK: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.3.1 Overview
        • 9.2.6.3.2 UK: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.3.3 UK: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.3.4 UK: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.3.4.1 UK: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.2.6.3.5 UK: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.2.6.4 Italy: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.4.1 Overview
        • 9.2.6.4.2 Italy: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.4.3 Italy: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.4.4 Italy: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.4.4.1 Italy: Eye Drops Market, For Antibiotics by Application, 2020-2030 (US$ Million)
        • 9.2.6.4.5 Italy: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.2.6.5 Spain: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.5.1 Overview
        • 9.2.6.5.2 Spain: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.5.3 Spain: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.5.4 Spain: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.5.4.1 Spain: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.2.6.5.5 Spain: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.2.6.6 Rest of Europe: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.6.1 Overview
        • 9.2.6.6.2 Rest of Europe: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.2.6.6.3 Rest of Europe: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.2.6.6.4 Rest of Europe: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.2.6.6.4.1 Rest of Europe: Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.2.6.6.5 Rest of Europe: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  • 9.3 Asia Pacific: Eye Drops Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Asia Pacific: Eye Drops Market, by Type, 2020-2030 (US$ Million)
    • 9.3.4 Asia Pacific: Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 9.3.4.1 Asia Pacific: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    • 9.3.5 Asia Pacific: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
    • 9.3.6 Asia Pacific: Eye Drops Market, by Country, 2022 & 2030 (%)
      • 9.3.6.1 China: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.1.1 Overview
        • 9.3.6.1.2 China: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.1.3 China: Eye Drops Market, by Drug Class, 2020-2030 (US$ Million)
        • 9.3.6.1.4 China: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.1.4.1 China: Eye Drops Market, by Eye Disease, 2020-2030 (US$ Million)
        • 9.3.6.1.5 China: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.3.6.2 Japan: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.2.1 Overview
        • 9.3.6.2.2 Japan: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.2.3 Japan: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.3.6.2.4 Japan: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.2.4.1 Japan: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
        • 9.3.6.2.5 Japan: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.3.6.3 India: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.3.1 Overview
        • 9.3.6.3.2 India: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.3.3 India: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.3.6.3.4 India: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.3.4.1 India: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
        • 9.3.6.3.5 India: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.3.6.4 Australia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.4.1 Overview
        • 9.3.6.4.2 Australia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.4.3 Australia: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.3.6.4.4 Australia: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.4.4.1 Australia: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
        • 9.3.6.4.5 Australia: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.3.6.5 South Korea: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.5.1 Overview
        • 9.3.6.5.2 South Korea: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.5.3 South Korea: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.3.6.5.4 South Korea: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.5.4.1 South Korea: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
        • 9.3.6.5.5 South Korea: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.3.6.6 Rest of Asia Pacific: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.6.1 Overview
        • 9.3.6.6.2 Rest of Asia Pacific: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.3.6.6.3 Rest of Asia Pacific: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.3.6.6.4 Rest of Asia Pacific: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.3.6.6.4.1 Rest of Asia Pacific: Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
        • 9.3.6.6.5 Rest of Asia Pacific: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  • 9.4 Middle East & Africa Eye Drops Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.4.3 Middle East & Africa: Eye Drops Market, by Type, 2020-2030 (US$ Million)
    • 9.4.4 Middle East & Africa: Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 9.4.4.1 Middle East & Africa: Eye Drops Market, by Eye Disease by Application, 2020-2030 (US$ Million)
    • 9.4.5 Middle East & Africa: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.4.5.1 South Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.1.1 Overview
        • 9.4.5.1.2 South Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.1.3 South Africa: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.4.5.1.4 South Africa: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.4.5.1.4.1 South Africa: Eye Drops Market, by Eye Disease by Application, 2020-2030 (US$ Million)
        • 9.4.5.1.5 South Africa: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.4.5.2 Saudi Arabia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.2.1 Overview
        • 9.4.5.2.2 Saudi Arabia: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.2.3 Saudi Arabia: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.4.5.2.4 Saudi Arabia: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.4.5.2.4.1 Saudi Arabia: Eye Drops Market, by Eye Disease by Application, 2020-2030 (US$ Million)
        • 9.4.5.2.5 Saudi Arabia: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.4.5.3 UAE: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.3.1 Overview
        • 9.4.5.3.2 UAE: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.3.3 UAE: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.4.5.3.4 UAE: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.4.5.3.4.1 UAE: Eye Drops Market, by Eye Disease by Application, 2020-2030 (US$ Million)
        • 9.4.5.3.5 UAE: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 9.4.5.4 Rest of Middle East & Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East & Africa: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.4.5.4.4 Rest of Middle East & Africa: Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 9.4.5.4.4.1 Rest of Middle East & Africa: Eye Drops Market, by Eye Disease by Application, 2020-2030 (US$ Million)
        • 9.4.5.4.5 Rest of Middle East & Africa: Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  • 9.5 South & Central America: Eye Drops Market
    • 9.5.1 Overview
    • 9.5.2 South & Central America: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.5.3 South & Central America: Eye Drops Market, by Type, 2020-2030 (US$ Million)
    • 9.5.4 South & Central America: Eye Drops Market, By Application, 2020-2030 (US$ Million)
      • 9.5.4.1 South & Central America: Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
    • 9.5.5 South & Central America: Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
    • 9.5.6 South & Central America: Eye Drops Market Share by Country - 2022 & 2030, (%)
      • 9.5.6.1 Brazil: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.6.1.1 Overview
      • 9.5.6.2 Brazil: Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
        • 9.5.6.2.1 Brazil: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.5.6.2.2 Brazil: Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 9.5.6.2.2.1 Brazil: Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.5.6.2.3 Brazil: Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
      • 9.5.6.3 Argentina: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.6.3.1 Overview
      • 9.5.6.4 Argentina: Eye Drops Market- Revenue and Forecasts to 2030 (US$ Million)
        • 9.5.6.4.1 Argentina: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.5.6.4.2 Argentina: Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 9.5.6.4.2.1 Argentina: Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.5.6.4.3 Argentina: Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)
      • 9.5.6.5 Rest of South & Central America: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.6.5.1 Overview
      • 9.5.6.6 Rest of South & Central America: Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.6.6.1 Rest of South & Central America: Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 9.5.6.6.2 Rest of South & Central America: Eye Drops Market, By Application, 2020-2030 (US$ Million)
        • 9.5.6.6.2.1 Rest of South & Central America: Eye Drops Market, for Eye Diseases by Application, 2020-2030 (US$ Million)
        • 9.5.6.6.3 Rest of South & Central America: Eye Drops Market, By Purchase Mode, 2020-2030 (US$ Million)

10. Pre and Post COVID-19 Impact on Eye Drops Market

  • 10.1 Pre and Post COVID-19 Impact

11. Eye Drops Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Eye Drop Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Akorn Operating Company LLC
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Alcon AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Pfizer Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Prestige Consumer Healthcare Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rohto Pharmaceutical Co Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Sager Pharma Kft
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Similasan Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 AbbVie Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bausch & Lomb Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Biomedica Pvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms